Literature DB >> 5031614

Corneal chrysiasis. A clinical study in rheumatoid arthritis patients receiving gold therapy.

A Hashimoto, Y Maeda, H Itŏ, M Okazaki, T Hara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5031614     DOI： 10.1002/art.1780150313

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  6 in total

1.  Chrysiasis in rheumatoid arthritis.

Authors:  M Bonet; A Olive; J Maymo; J Cucurull; A Nogueroles; C Arnal
Journal:  Clin Rheumatol       Date:  1990-06       Impact factor: 2.980

Review 2.  Ocular toxicity from systemically administered xenobiotics.

Authors:  Mitan R Gokulgandhi; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-07-18       Impact factor: 4.481

Review 3.  Adverse reactions with oral and parenteral gold preparations.

Authors:  E C Tozman; N L Gottlieb
Journal:  Med Toxicol       Date:  1987 May-Jun

4.  Corneal chrysiasis and clinical improvement with chrysotherapy in rheumatoid arthritis.

Authors:  P J Prouse; J J Kanski; J M Gumpel
Journal:  Ann Rheum Dis       Date:  1981-12       Impact factor: 19.103

Review 5.  Gold-based therapy: From past to present.

Authors:  Alice Balfourier; Jelena Kolosnjaj-Tabi; Nathalie Luciani; Florent Carn; Florence Gazeau
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-08       Impact factor: 11.205

6.  Gold nanoparticles: a revival in precious metal administration to patients.

Authors:  A S Thakor; J Jokerst; C Zavaleta; T F Massoud; S S Gambhir
Journal:  Nano Lett       Date:  2011-09-07       Impact factor: 11.189
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.